Lisocabtagene Maraleucel

6 trials 4 recruiting NNeurology/Psychiatry Orphan designation

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

5 Sponsors

17 Countries

Phase II/III

Phase II

Phase IV

Phase II/III: 1 Phase II: 4 Phase IV: 1

Indications tested

Diffuse large B-cell lymphoma recurrent 1 Nodal marginal zone B-cell lymphoma 1 Marginal zone lymphoma 1 Diffuse large B-cell lymphoma refractory 1

Sponsors using this IMP

Celgene Corp. 2 Bristol-Myers Squibb Services Unlimited Company 1 Centre Hospitalier Universitaire De Saint Etienne 1 Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH 1 Lymphoma Academic Research Organisation 1

All trials

6 total

Double-T - Improving outcomes in high-risk 2nd line relapsed/refractory Large B-Cell Lymphoma patients eligible for CAR-T-cell therapy with … Pending

2025-523806-34-00 Phase II 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) as First-Line Therapy in Adults with Transplant-Ineligible Primary Central Nervou… Recruiting

2025-521144-38-00 Phase II 2 countries Bristol-Myers Squibb Services Unlimited Company
Temporal characterization of Extracellular Vesicles during cellular therapy using CAR-T cells and during the occurrence of Immune effector C… Recruiting

2024-515328-35-00 Phase IV 1 country Centre Hospitalier Universitaire De Saint Etienne
CARMOD - Golcadomide (BMS-986369) post-CAR T-cell in R/R Aggressive large B-cell lymphoma patients with high risk of relapse Recruiting

2023-506705-20-00 Phase II 1 country Lymphoma Academic Research Organisation
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting

2023-504201-36-00 Phase II/III 17 countries Celgene Corp.
A study to evaluate the efficacy and safety of JCAR017 in adult subjects with a type of cancer that affects B-cells, a type of white blood c… Ended

2024-510966-18-00 Phase II 6 countries Celgene Corp.

Showing 1–6 of 6 trials

← All drugs A–Z